Miami, FL, February 22, 2021 – — AllStar Health Brands Inc. (OTC Pink: ALST) a specialty pharmaceutical and nutritional supplements company and Gold River Productions Inc. (OTC Pink: GRPS) are pleased to announce Management of both companies have signed a Distribution Agreement for the Marketing & Sales of four initial products. DEFENDER – a throat spray that soothes sore throats whether from viral, bacterial or surgical cause. With powerful natural ingredients known to be effective against viruses and bacteria in the laboratory setting, this spray represents what we believe to be the first of its kind commercial approach to soothe sore throats. In addition, we will be adding an exciting new line of rare cannabinoid gummies packed with large amounts of CBG, CBN, and full spectrum CBD. With blends that are doctor formulated to help with sleep, pain and anxiety, the initial public reception is very enthusiastic and it gives the public a very viable alternative to the toxic pharmaceutical regimens that currently exist.
Dr. Daniel Bagi, President of AllStar remarked, “This agreement culminates months of work from both parties, and AllStar is extremely pleased with the opportunity to co-market these high-demand products developed over several years by Gold River Productions. The DEFENDER throat spray we believe could be an adjunct in everyday use as part of the hygienic arsenal available to the public and help in the battle against sore throats from any cause. The natural ingredients in the formula have shown in vitro antiviral and pain-reduction properties, and anecdotal evidence strongly supports this.”
Dr. Bagi further observed. “We are formulating high-octane products that we feel compete with toxic pharmaceuticals without the side effects. We are equally excited about the line of gummies developed by Gold River Productions, which have unique formulations of rare cannabinoids. Emphasizing the addition of larger quantities of CBG and CBN in addition to full-spectrum CBD, we now have the formulation that demonstrates the most efficacy. The feedback we have received from early samplers support these unique formulations’ ability to be a natural alternative in certain health conditions, such as an aid to insomnia, pain, and anxiety.” “AllStar strongly believes the stresses associated with the pandemic have added to the attractiveness of effective cannabinoid and natural products. People want alternatives. We see a sharp uptick in the demand for these formulations over the near and long-term,” added Dr. Bagi. “Our future line of products is even more exciting and we can’t wait to introduce them. We have four physicians on staff with impressive backgrounds. They are all dedicated to making peoples’ lives better.”
Dr Richard Goulding, CEO of Gold River Productions, stated: “My background as an ear, nose, and throat doctor as well as my association with two physicians with immense nutraceutical background has helped us develop these unique and natural product formulations over the years. We have tested these products on individuals in a random sampling, and the results are very encouraging. While the need for double-blind testing is imperative and something that we shall seek to perform, the need and safety makes these products attractive now. We expect the demand for these products to be especially high given that they are natural alternatives to some currently prescribed drugs. People are seeking alternative and effective solutions for common afflictions. We intend to deliver just that.”
AllStar expects to begin co-marketing in the US in Q2 2021, in Florida and other US locations as well as Canada and Mexico once any regulatory hurdles have been satisfied. All Star has unique access to multiple locations.
About Gold River Productions Inc. GRPS:
Gold River will focus on market-targeted products including, but not limited to rare cannabinoids and effective products where a particular need is identified. Products for pain relief, sleep, etc. that will be distributed through convenience stores, independent pharmacies and more will have mass appeal to the market.
About AllStar Health Brands Inc.:
AllStar Health Brands Inc. is a Nevada Corporation established in 2017, and headquartered in Miami, Florida. AllStar is a specialty HealthCare Products Company dedicated to improving health and quality of life by offering select, nutritional supplements, over the counter remedies, and medicines all across the Americas and Europe. AllStar’s goal is to bring additional products to the market and provide new, innovative options for better health and wellbeing.
For more information, please contact Investor Relations at: (305) 423 7028.
Safe Harbor Statement
Statements about the Company’s future expectations and all other statements in this press release other than historical facts, are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.
The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words “anticipate,” “estimate,” “expect,” “intend,” “plans,” “projects,” and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.